<DOC>
	<DOCNO>NCT02301312</DOCNO>
	<brief_summary>This study evaluate safety performance new vascular graft make POSS-PCU vascular access conduit haemodialysis . 30 patient require access dialysis enrol monitor regular interval 18 month .</brief_summary>
	<brief_title>Clinical Study POSS-PCU Vascular Grafts Vascular Access</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Subjects require vascular access haemodialysis Subjects suitable vein . Subjects age 18 80 year old Subjects able give voluntary , write informed consent participate clinical investigation consent obtain Patients child bear potential , sexually active , must agree use 2 highly effective form contraception throughout participation study 6 month completion treatment : Condom spermicide . AND 1 following : Oral contraceptive hormonal therapy ( e.g . hormone implant ) . Placement intrauterine device . Subjects predict shortterm survival ( le 18 month ) poor prognosis ( discretion clinician charge ) Subjects left ventricle ejection fraction ( LVEF ) &lt; 20 % diagnose ECHO either preprocedure document within previous 3 month prior consent . Pregnant lactate Allergies constituent graft material Patients infected colonized Methicillin Resistant Staphylococcus Aureus ( MRSA ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>